A population-based study of the clinical course of chronic fatigue syndrome

  • PDF / 516,484 Bytes
  • 9 Pages / 610 x 792 pts Page_size
  • 1 Downloads / 171 Views

DOWNLOAD

REPORT


Open Access

Research

A population-based study of the clinical course of chronic fatigue syndrome Rosane Nisenbaum*1, James F Jones2, Elizabeth R Unger1, Michele Reyes1,3 and William C Reeves1 Address: 1Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 2Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado, USA and 3Division of Nutrition and Physical Activity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Email: Rosane Nisenbaum* - [email protected]; James F Jones - [email protected]; Elizabeth R Unger - [email protected]; Michele Reyes - [email protected]; William C Reeves - [email protected] * Corresponding author

Published: 03 October 2003 Health and Quality of Life Outcomes 2003, 1:49

Received: 01 May 2003 Accepted: 03 October 2003

This article is available from: http://www.hqlo.com/content/1/1/49 © 2003 Nisenbaum et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Abstract Background: Chronic fatigue syndrome (CFS) presents a challenge for patients, health care providers, and health insurance groups because of its incapacitating nature, unknown cause, and poorly understood prognosis. We conducted a longitudinal population-based study to characterize the clinical course of CFS. Methods: Sixty-five CFS subjects were identified from a random-digit-dialing survey of Wichita, Kansas residents and followed for up to 3 years. We evaluated changes in CFS classification (partial or total remission, alternative medical or psychiatric diagnoses), CFS case-defining criteria, wellness scores, hours of activities and sleep, and treatments used to reduce fatigue. Associations between risk factors and outcomes were determined by use of logistic regression and generalized estimating equations models. Results: Only 20%-33% of the subjects were classified as having CFS at follow-up, 56.9% ever experienced partial or total remission, 10% sustained total remission, and 23.1% received alternative diagnoses, of which 20% were sleep disorders. Higher fatigue severity scores and total number of symptoms were negatively associated with ever remitting. Duration of illness ≤ 2 years was positively associated with sustained remission. Unrefreshing sleep persisted in at least 79% of the subjects across all periods but, as with most of the CFS symptoms, tended to be less frequent over time. The number of activities affected by fatigue decreased over time, while wellness scores increased. At any follow-up, more than 35% of subjects reporting reduced fatigue used complementary and alternative medicine therapies, and of those subjects, at least 50% thought these therapies were responsible for reducing their fati